サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1644034

ヘルスケアにおける生成AIの世界市場

Generative Artificial Intelligence in Healthcare

出版日
ページ情報
英文 191 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケアにおける生成AIの世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアにおける生成AIの世界市場は2030年までに170億米ドルに到達

2024年に27億米ドルと推定されるヘルスケアにおける生成AIの世界市場は、分析期間2024年から2030年にかけて36.0%のCAGRで成長し、2030年には170億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるヘルスケア生成AIソリューションは、CAGR34.6％を記録し、分析期間終了までに97億米ドルに達すると予測されます。ヘルスケア生成AIサービスセグメントの成長率は、分析期間でCAGR 38.1%と推定されます。

米国市場は7億440万米ドルと推定、中国はCAGR34.3％で成長予測

米国のヘルスケアにおける生成AI市場は、2024年に7億440万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに25億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは34.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ32.7％と31.4％と予測されています。欧州では、ドイツがCAGR 25.3%で成長すると予測されています。

世界のヘルスケアにおける生成AI市場- 主要動向と促進要因のまとめ

ヘルスケアにおける生成AIの変革能力とは？

生成AIは、複雑なデータセットを分析し、予測モデルを生成する能力を活用することでヘルスケアを再形成し、診断、治療、患者ケアにおける画期的な進歩を可能にしています。膨大な量の患者データ、医療記録、画像スキャンを活用することで、AIアルゴリズムは正確かつタイムリーな洞察を提供し、臨床転帰を大幅に向上させることができます。既存のパターンから新しいデータを作成する生成AIの能力は、画像診断において特に有用であり、がん、心臓疾患、神経疾患などの疾患を比類のない精度で特定します。診断にとどまらず、この技術は複雑な生物学的システムのモデリングを支援し、病気の進行や治療効果のシミュレーションをイン・シリコで可能にすることで、コストと時間のかかる物理的実験への依存を軽減します。個別化医療は、生成AIの主要な応用例として登場しました。個々の患者の遺伝子やライフスタイルのプロファイルに合わせて治療を調整することで、AIは副作用を最小限に抑えた最適な治療を実現します。さらに、このテクノロジーは、まれで複雑な病状をシミュレートすることで、医療教育やトレーニングをサポートし、臨床医が管理された環境でスキルを磨けるようにします。生成AIのこうした変革能力は、ヘルスケア提供の未来の礎石としての地位を確立しています。

なぜ製薬業界が生成AI導入の最前線にいるのか？

生成AIが創薬と開発を加速させる中、製薬業界はパラダイムシフトを経験しています。このテクノロジーは、新薬の上市に伴う従来は法外な時間とコストを大幅に削減します。AI主導のプラットフォームは、有望な分子化合物を特定し、それらの相互作用をシミュレートし、薬理学的特性を予測することで、前臨床段階を合理化します。生成AIは、仮想医薬品試験と計算予測を容易にすることで、後期段階での失敗の可能性を最小限に抑え、より高い成功率と迅速な承認プロセスを保証します。薬剤の再利用におけるAIの役割も、ゲームチェンジャーであることが証明されています。既存のデータセットを分析し、既存薬の新たな用途を探索することで、製薬会社は満たされていない医療ニーズに効率的に対応することができます。さらに、生成AIは、最適な患者コホートを選択し、試験プロトコールを確実に遵守し、リアルタイムのデータを分析して異常を特定することで、臨床試験管理を強化します。これらのイノベーションは、医薬品開発のスピードと精度を向上させるだけでなく、費用対効果にも貢献し、重要な治療法のより強固なパイプラインを育成します。

ヘルスケアプロバイダーはどのように生成AIを業務に組み込んでいるのか？

病院やヘルスケアプロバイダーは、業務効率、患者ケア、リソース利用を改善するために生成AIを導入しています。AIを搭載したシステムは、予約スケジューリングや請求からデータ管理やコンプライアンス監視に至るまで、管理ワークフローに革命をもたらし、ヘルスケアスタッフは患者との直接対話に集中できるようになっています。AIを電子カルテ（EHR）と統合することで、臨床医は正確な最新情報にアクセスできるようになり、より迅速で十分な情報に基づいた意思決定が可能になります。遠隔医療は、AI対応のバーチャルアシスタントや診断ツールにも後押しされ、急激な成長を遂げています。これらのプラットフォームは、特にサービスが行き届いていない地域や農村部において、リアルタイムの洞察やモニタリング機能を提供することで、遠隔診察の質を高めています。さらに、AIを活用した予測分析は、患者の入院動向を予測し、スタッフの配置を最適化することで、病院のリソース計画をサポートします。生成的AIによって誘導されるロボット支援手術は、精度の新たな基準を設定し、回復時間を短縮しています。これらの進歩は、AIがヘルスケアのエコシステムに統合されつつあることを反映しており、医療提供者と患者の転帰を確実に改善します。

ヘルスケアにおける生成AI市場の成長を促進する要因とは？

ヘルスケアにおける生成AI市場の成長は、ヘルスケアデータ量の増加、計算能力の進歩、個別化ケアに対する需要の高まりなど、いくつかの重要な要因によって牽引されています。製薬企業によるAIの採用は、より迅速な創薬とコスト削減を可能にし、大きな触媒となっています。さらに、遠隔医療サービスや遠隔医療ソリューションの拡大が、特に医療アクセスが限られている地域において、シームレスで効率的な患者管理を促進するAI搭載プラットフォームへの需要を促進しています。精密医療とオーダーメイド治療に対する消費者の期待は、医療提供者を、患者の満足度と臨床転帰を向上させる生成AIツールの導入に駆り立てています。保険会社もまた、不正検知、リスク評価、個別化された保険契約の作成にAIを活用するようになっており、ヘルスケアの現場全体でこの技術の応用範囲が広がっています。さらに、政府と民間団体はAIの研究とイノベーションに多額の投資を行っており、規制機関は倫理的な展開と相互運用性を確保するために適応しています。これらの要因の総体として、ヘルスケア分野における生成AIの変革的なインパクトと、世界な医療システムの未来を形成する役割が強調されています。

セグメント

コンポーネント（ソリューション・コンポーネント、サービス・コンポーネント）、機能（医療画像解析機能、バーチャル看護アシスタント機能、ロボット支援AI手術機能、事務プロセス最適化機能）、用途（臨床用途、システム用途）、最終用途（臨床研究最終用途、医療センター最終用途、診断センター最終用途、その他最終用途）

調査対象企業の例（計27社に注目）

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP31170

Global Generative Artificial Intelligence in Healthcare Market to Reach US$17.0 Billion by 2030

The global market for Generative Artificial Intelligence in Healthcare estimated at US$2.7 Billion in the year 2024, is expected to reach US$17.0 Billion by 2030, growing at a CAGR of 36.0% over the analysis period 2024-2030. Healthcare Generative AI Solutions, one of the segments analyzed in the report, is expected to record a 34.6% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the Healthcare Generative AI Services segment is estimated at 38.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.4 Million While China is Forecast to Grow at 34.3% CAGR

The Generative Artificial Intelligence in Healthcare market in the U.S. is estimated at US$704.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 34.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.7% and 31.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.3% CAGR.

Global Generative Artificial Intelligence in Healthcare Market – Key Trends & Drivers Summarized

What Are the Transformative Capabilities of Generative AI in Healthcare?

Generative Artificial Intelligence is reshaping healthcare by leveraging its ability to analyze complex datasets and generate predictive models, enabling breakthroughs in diagnostics, treatment, and patient care. By harnessing vast volumes of patient data, medical records, and imaging scans, AI algorithms can deliver precise and timely insights that significantly enhance clinical outcomes. Generative AI's ability to create new data from existing patterns is particularly valuable in imaging diagnostics, where it identifies diseases such as cancer, heart conditions, and neurological disorders with unparalleled accuracy. Beyond diagnostics, the technology aids in modeling complex biological systems, allowing for the simulation of disease progression and treatment efficacy in silico, reducing the reliance on costly and time-intensive physical experiments. Personalized medicine has emerged as a flagship application of generative AI. By tailoring treatments to individual patients' genetic and lifestyle profiles, AI ensures optimized care with minimal adverse effects. Furthermore, the technology supports medical education and training by simulating rare and complex medical conditions, empowering clinicians to refine their skills in controlled environments. These transformative capabilities of generative AI have established it as a cornerstone of the future of healthcare delivery.

Why Is the Pharmaceutical Sector at the Forefront of Generative AI Adoption?

The pharmaceutical industry is experiencing a paradigm shift as generative AI accelerates drug discovery and development. This technology significantly reduces the traditionally prohibitive time and cost associated with bringing new drugs to market. AI-driven platforms identify promising molecular compounds, simulate their interactions, and predict pharmacological properties, streamlining the preclinical phase. By facilitating virtual drug trials and computational predictions, generative AI minimizes the likelihood of late-stage failures, ensuring higher success rates and faster approval processes. AI's role in drug repurposing has also proven to be a game-changer. By analyzing existing datasets and exploring new applications for established drugs, pharmaceutical companies can address unmet medical needs more efficiently. Furthermore, generative AI enhances clinical trial management by selecting optimal patient cohorts, ensuring adherence to study protocols, and analyzing real-time data to identify anomalies. These innovations not only improve the speed and accuracy of drug development but also contribute to cost-effectiveness, fostering more robust pipelines for critical therapies.

How Are Healthcare Providers Integrating Generative AI Into Operations?

Hospitals and healthcare providers are embracing generative AI to improve operational efficiency, patient care, and resource utilization. AI-powered systems are revolutionizing administrative workflows, from appointment scheduling and billing to data management and compliance monitoring, allowing healthcare staff to focus on direct patient interactions. Integrating AI with electronic health records (EHRs) ensures that clinicians have access to accurate, up-to-date information, enabling faster and more informed decision-making. Telemedicine has witnessed exponential growth, driven in part by AI-enabled virtual assistants and diagnostic tools. These platforms enhance the quality of remote consultations by offering real-time insights and monitoring capabilities, particularly in underserved and rural areas. Additionally, predictive analytics powered by AI supports hospitals in resource planning by forecasting patient admission trends and optimizing staff deployment. Robotic-assisted surgeries, guided by generative AI, are setting new benchmarks for precision and reducing recovery times. Together, these advancements reflect the growing integration of AI into healthcare ecosystems, ensuring improved outcomes for providers and patients alike.

What Factors Are Driving the Growth of the Generative AI in Healthcare Market?

The growth of the Generative Artificial Intelligence in Healthcare market is driven by several key factors, including the increasing volume of healthcare data, advancements in computational power, and the rising demand for personalized care. The adoption of AI by pharmaceutical companies has been a major catalyst, enabling faster drug discovery and reducing costs. Moreover, the expansion of telehealth services and remote care solutions has fueled demand for AI-powered platforms that facilitate seamless and efficient patient management, particularly in areas with limited healthcare access. Consumer expectations for precision medicine and tailored treatments have pushed healthcare providers to adopt generative AI tools that enhance patient satisfaction and clinical outcomes. Insurers are also turning to AI for fraud detection, risk assessment, and personalized policy creation, broadening the technology's application across the healthcare landscape. Additionally, governments and private entities are making significant investments in AI research and innovation, with regulatory bodies adapting to ensure ethical deployment and interoperability. These factors collectively underscore the transformative impact of generative AI on the healthcare sector and its role in shaping the future of global health systems.

SCOPE OF STUDY:

The report analyzes the Generative Artificial Intelligence in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Function (Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function, Administrative Process Optimization Function); Application (Clinical Application, System Application); End-Use (Clinical Research End-Use, Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 27 Featured) -

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Generative Artificial Intelligence in Healthcare - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Generative AI Spurs Growth in Diagnostics and Personalized Healthcare Solutions
    • Expansion of Predictive Analytics Tools Broadens Addressable Market in Patient Care
    • Increased Demand for Virtual Health Assistants Drives AI Adoption in Telemedicine
    • Generative AI Revolutionizes Drug Discovery and Accelerates Development Timelines
    • Automation of Administrative Workflows Strengthens the Business Case for AI in Healthcare
    • AI-Driven Advances in Medical Imaging Propel Growth in Radiology Applications
    • IoMT Integration Sustains Growth Opportunities for AI in Connected Healthcare Systems
    • AI-Powered Clinical Decision Support Systems Propel Adoption Across Healthcare Facilities
    • Generative AI Addresses Workforce Shortages by Optimizing Healthcare Delivery
    • AI Innovations Enhance Market Potential for Mental Health Solutions
    • AI-Based Simulation Tools Drive Adoption in Medical Training and Education Programs
    • Precision Oncology Gains Momentum with Generative AI-Enabled Targeted Therapies
    • Data Privacy and Security Challenges Influence Market Dynamics and Adoption Rates
    • AI-Enhanced Patient Engagement Models Create New Opportunities in Care Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Generative Artificial Intelligence in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Medical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Medical Imaging Analysis Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Medical Imaging Analysis Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Virtual Nursing Assistants Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Virtual Nursing Assistants Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Robot-Assisted AI Surgery Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Robot-Assisted AI Surgery Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Administrative Process Optimization Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Administrative Process Optimization Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • JAPAN
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CHINA
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • EUROPE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • FRANCE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • GERMANY
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030

IV. COMPETITION